PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Mar-2025 Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Genmab A/S
04-Mar-2025 OncoZenge AB receives positive assessment regarding the PCT-patent application for BupiZenge™ OncoZenge AB
04-Mar-2025 New OHE research finds productivity losses from respiratory infections cost UK businesses £44 billion per year OHE
04-Mar-2025 Carbon Minimal pressurised Metered Dose Inhalers (pMDIs) could save up to 619,000 tonnes of emissions each year,[i] representing up to 7%-10% of NHS Net Zero targets[ii] The Office of Health Economics (OHE)
04-Mar-2025 FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics FibroBiologics
04-Mar-2025 Mestag Therapeutics Appoints Dr. Matthew Sleeman as Chief Scientific Officer Mestag Therapeutics
04-Mar-2025 Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial Tiziana Life Sciences
04-Mar-2025 AC Immune to Participate in Upcoming Investor Conferences AC Immune
04-Mar-2025 Alithia Choose Flex Databases as eTMF provider Flex Databases
04-Mar-2025 Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials Mural Health
04-Mar-2025 Stryker launches Sync Badge Stryker
04-Mar-2025 ​​Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials​ ICON
04-Mar-2025 Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera Takeda
04-Mar-2025 AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity AbbVie
04-Mar-2025 Depemokimab applications accepted for review by the US FDA for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps (CRSwNP) GSK
04-Mar-2025 Imfinzi-based perioperative regimen recommended for approval in the EU by CHMP for resectable non-small cell lung cancer AstraZeneca
04-Mar-2025 Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb Evotec
04-Mar-2025 Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer’s Disease in Australia Eisai
04-Mar-2025 Influenza Diagnostics Market Revenue to Exceed $2.0 Bn by 2031 Amid Rising Cases and Demand for Rapid Testing – TMR Insights Transparency Market Research
04-Mar-2025 Rising Demand for Regenerative Medicine to Drive Stem Cell Assays Market to $8.5 Bn by 2033 at a CAGR of 16.5% - Latest Report by TMR Transparency Market Research